| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|
Allena Pharmaceuticals
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Allena Pharmaceuticals, Inc. engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes Reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults. The company was founded by Robert Gallotto and Alexey L. Margolin on June 24, 2011.
Ticker: ALNA
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1624658
Employees:
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Restructuring Charges of $600 Th for the period Nov 2019 to Nov 2019 in the context of all up
Fundamentals
News
What we know about Amy Coney Barrett's judicial abortion record
26th September 2020
What Amy Coney Barrett on the Supreme Court would mean for abortion rights
25th September 2020
What we know about Amy Coney Barrett's judicial abortion record
25th September 2020
Some 3,500 US companies sue over Trump-imposed Chinese tariffs
25th September 2020
US judge expected to decide by Sunday if TikTok will remain in US app stores
25th September 2020
US tells judge it opposes TikTok effort to halt app store ban
25th September 2020